How many institutions held BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share in Q3 2023?

29 institutional investors reported BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share for Q3 2023. Use the holders table for investor-level position and value details.

BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Q: What does CUSIP 09071M205 represent in this 13F holders report?

CUSIP 09071M205 is the security identifier for BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share used to aggregate holder disclosures.

CUSIP: 09071M205

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Ordinary shares, par value NIS 0.10 per share
Total 13F shares: 1,353,450
Total 13F value: $2,463,071
Share change: +116,016
Put/Call ratio: 108%
SEC-reported price per share: $1.82
Number of holders: 29
Value change: +$250,703
Number of buys: 16
Number of sells: 10
Shares outstanding: 2,048,819,940

Security key

09071M205

Report period

Q3 2023

Institutions

Top holders

BLRX full security history Ownership snapshot Full 13F holder table BioLineRx Ltd. SEC filings BioLineRx Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

15/15

Latest evidence

30 Jun 2023

13F Lead comparable stake: 0.01% Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 0.01%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 0.01%

CITADEL ADVISORS LLC 0.01%

LPL Financial LLC 0.01%

Atria Wealth Solutions, Inc. 0.01%

RENAISSANCE TECHNOLOGIES LLC 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	0.01%	$416,257 260,976 shares	—	30 Jun 2023
CITADEL ADVISORS LLC	13F Company 13F	0.01%	$339,367 212,769 shares	—	30 Jun 2023
LPL Financial LLC	13F Company 13F	0.01%	$199,710 125,210 shares	—	30 Jun 2023
Atria Wealth Solutions, Inc.	13F Company 13F	0.01%	$176,034 110,366 shares	—	30 Jun 2023
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0%	$157,000 98,710 shares	—	30 Jun 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	0%	$134,136 84,098 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,353,450

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %